» Articles » PMID: 28473613

Exercise Training and Metformin, but Not Exercise Training Alone, Decreases Insulin Production and Increases Insulin Clearance in Adults with Prediabetes

Overview
Date 2017 May 6
PMID 28473613
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Adding metformin to exercise does not augment the effect of training alone to boost whole body insulin sensitivity and lower circulating insulin concentrations. Although lower insulin concentrations (lower supply) following lifestyle and/or pharmacological interventions are primarily attributed to reductions in insulin secretion that match increases in peripheral insulin sensitivity (lower demand), it is unclear whether exercise and/or metformin exert direct effects on insulin production, extraction, or clearance. Thirty-six middle-aged, obese, sedentary adults with prediabetes were randomized to placebo (P), metformin (M), exercise and placebo (E+P), or exercise and metformin (E+M) for 12 wk. Fasting plasma proinsulin (an indicator of insulin production), C-peptide, insulin, and glucose were collected before and after the intervention. Peripheral insulin sensitivity (euglycemic clamp), hepatic insulin extraction, insulin clearance, body weight, and cardiorespiratory fitness were also measured. Fasting proinsulin was unchanged following P (19.4 ± 10.1 vs. 22.6 ± 15.0 pmol/l), E+P (15.1 ± 7.4 vs. 15.5 ± 7.4 pmol/l), or M (24.8 ± 18.9 vs. 16.7 ± 20.3 pmol/l) but was significantly reduced after E+M (18.6 ± 11.9 vs. 13.9 ± 6.7 pmol/l; = 0.04). Insulin clearance was significantly greater following M (384.6 ± 19.4 vs. 477.4 ± 49.9; = 0.03) and E+M (400.1 ± 32.0 vs. 482.9 ± 33.9; = 0.02) but was unchanged in P or E+P. In this study, metformin combined with exercise training reduced circulating proinsulin, and both groups taking metformin increased insulin clearance. This suggests that adding metformin to exercise may augment or attenuate training effects depending on the outcome or organ system being assessed. Exercise is increasingly viewed as medication, creating a need to understand its interactions with other common medications. Research suggests metformin, a widely prescribed diabetes medication, may diminish the benefits of exercise when used in combination. In this study, however, metformin combined with exercise training, but not exercise alone, lowered proinsulin concentrations and increased insulin clearance in adults with prediabetes. This may directly influence personalized prescriptions of lifestyle and/or pharmacology to reduce diabetes risk.

Citing Articles

Metformin plus lifestyle interventions versus lifestyle interventions alone for the delay or prevention of type 2 diabetes in individuals with prediabetes: a meta-analysis of randomized controlled trials.

Amer B, Shaaban Abdelgalil M, Hamad A, Abdelsayed K, Elaraby A, Abozaid A Diabetol Metab Syndr. 2024; 16(1):273.

PMID: 39543645 PMC: 11562588. DOI: 10.1186/s13098-024-01504-8.


Recent advances in understanding the mechanisms in skeletal muscle of interaction between exercise and frontline antihyperglycemic drugs.

Newsom S, Robinson M Physiol Rep. 2024; 12(11):e16093.

PMID: 38845596 PMC: 11157199. DOI: 10.14814/phy2.16093.


Metabolic disorders in prediabetes: From mechanisms to therapeutic management.

Ping W, Hu S, Su J, Ouyang S World J Diabetes. 2024; 15(3):361-377.

PMID: 38591088 PMC: 10999048. DOI: 10.4239/wjd.v15.i3.361.


Effect of physical activity and different exercise modalities on glycemic control in people with prediabetes: a systematic review and meta-analysis of randomized controlled trials.

Bennasar-Veny M, Malih N, Galmes-Panades A, Hernandez-Bermudez I, Garcia-Coll N, Ricci-Cabello I Front Endocrinol (Lausanne). 2023; 14:1233312.

PMID: 37842295 PMC: 10569497. DOI: 10.3389/fendo.2023.1233312.


Exercise precision medicine for type 2 diabetes: Targeted benefit or risk?.

LE S, Schumann M, Lei S, Yao W, Cheng S Sports Med Health Sci. 2023; 5(2):146-150.

PMID: 37424530 PMC: 10323910. DOI: 10.1016/j.smhs.2023.02.003.


References
1.
Toffolo G, Campioni M, Basu R, Rizza R, Cobelli C . A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction. Am J Physiol Endocrinol Metab. 2005; 290(1):E169-E176. DOI: 10.1152/ajpendo.00473.2004. View

2.
Jenkins N, Padilla J, Arce-Esquivel A, Bayless D, Martin J, Leidy H . Effects of endurance exercise training, metformin, and their combination on adipose tissue leptin and IL-10 secretion in OLETF rats. J Appl Physiol (1985). 2012; 113(12):1873-83. PMC: 3544496. DOI: 10.1152/japplphysiol.00936.2012. View

3.
Masini M, Anello M, Bugliani M, Marselli L, Filipponi F, Boggi U . Prevention by metformin of alterations induced by chronic exposure to high glucose in human islet beta cells is associated with preserved ATP/ADP ratio. Diabetes Res Clin Pract. 2014; 104(1):163-70. DOI: 10.1016/j.diabres.2013.12.031. View

4.
Kim S, Liu A, Ariel D, Abbasi F, Lamendola C, Grove K . Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study. Diabetologia. 2013; 57(3):455-62. PMC: 5072364. DOI: 10.1007/s00125-013-3134-3. View

5.
Leclerc I, Woltersdorf W, da Silva Xavier G, Rowe R, Cross S, Korbutt G . Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab. 2004; 286(6):E1023-31. DOI: 10.1152/ajpendo.00532.2003. View